DrugPatentWatch Database Preview

ORTHO-NOVUM 7/7/7-21 Drug Profile

When do Ortho-novum 7/7/7-21 patents expire, and when can generic versions of Ortho-novum 7/7/7-21 launch?

Ortho-novum 7/7/7-21 is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in ORTHO-NOVUM 7/7/7-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for ORTHO-NOVUM 7/7/7-21

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	3
Bulk Api Vendors:	4
Patent Applications:	2
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ORTHO-NOVUM 7/7/7-21
DailyMed Link:	ORTHO-NOVUM 7/7/7-21 at DailyMed

Drug patent expirations by year for ORTHO-NOVUM 7/7/7-21

Synonyms for ORTHO-NOVUM 7/7/7-21

(17 alpha)-17-hydroxy-19-norpregn-4-en-20-yn-3-one, mixture with (17 alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
(17alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one, mixture with (17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2,4,6-TRIENE-5,14-DIOL; (1S,2R,10R,11S,14R,15S)-14-ETHYNYL-14-HYDROXY-15-METHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-5-ONE
(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one; (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanth
19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, mixed with 19-nor-17-alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol
37270-71-6
53464-69-0
AC1L1Y1Y
Alyacen 1/35
Alyacen 7/7/7
Aranelle
Balziva
Balziva-21
Balziva-28
Binovum
BREVICON 21-DAY
BREVICON 28-DAY
Brevion
C20H24O2.C20H26O2
Con-fer
Cyclafem 1/35
Cyclafem 7/7/7
DT 5061
DT 5062
DT-5061
DT-5062(1/35)
Duagynon
E-Con
Ethinyl estradiol mixture with norethindrone
ETHINYL ESTRADIOL; NORETHINDRONE
Ethinylestradiol-norethisterone mixt
Ethinylestradiol-norethisterone mixt.
Ethynylestradiol mixed with norethindrone
ethynylestradiol mixture with norethindrone
Eve 20
Femcon Fe
GENCEPT 10/11-21
GENCEPT 10/11-28
Gynovlar
Leena
Lo Minastrin Fe
LoDose
LS-178555
LS-97443
MODICON 21
MODICON 28
N.E.E. 1/35 21
N.E.E. 1/35 28
N049500000
Necon 7/7/7 28-Day Tablets
Neocon
Netasyn
NORCEPT-E 1/35 21
NORCEPT-E 1/35 28
NORETHIN 1/35E-21
NORETHIN 1/35E-28
Norethindron-ethinylestradiol mixt
Norethindron-ethinylestradiol mixt.
Norethindrone / Ethinyl estradiol
NORETHINDRONE AND ETHINYL ESTRADIOL
NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)
NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
Norethindrone Ethinyl Estradiol
Norethindrone mixed with ethynylestradiol
Norethindrone mixture with ethinyl estradiol
Norethindrone-ethinylestradiol mixt
Norethindrone-ethinylestradiol mixt.
Norethisterone mixed with ethinyl oestradiol
Norethisterone-ethinylestradiol mixt
Norethisterone-ethinylestradiol mixt.
Norethisterone-ethynylestradiol mixt
Norethisterone-ethynylestradiol mixt.
Norimen
Norimin
Norinyl 1 35
Norinyl 1-35
NORINYL 1+35 21-DAY
NORINYL 1+35 28-DAY
Norminest
Nortrel 0.5/35-21
Nortrel 0.5/35-28
Nortrel 1/35-21
Nortrel 1/35-28
Nortrel 7/7/7
Oestro-primolut
Ortho Novum 7-7-7
Ortho-Novum 1/35
ORTHO-NOVUM 1/35-21
ORTHO-NOVUM 1/35-28
Ortho-novum 10/11
ORTHO-NOVUM 10/11-21
Ortho-Novum 10/11-28
ORTHO-NOVUM 7/14-21
ORTHO-NOVUM 7/14-28
Ortho-novum 7/7/7
ORTHO-NOVUM 7/7/7-28
Ortho-Novum 777
Ovcon 35
Ovcon 50
OVCON-35
OVCON-50
Ovyrmen
Ovysmen
PL055333
Primidos
SCHEMBL3835489
SH 7.1122
SH B 259 AB
TRI-NORINYL 21-DAY
TRI-NORINYL 28-DAY
Trinovum
Zenchent
Zoran

US Patents and Regulatory Information for ORTHO-NOVUM 7/7/7-21

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Pharms	ORTHO-NOVUM 7/7/7-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018985-001	Apr 4, 1984		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

or, see our see our flat-rate plans

Expired US Patents for ORTHO-NOVUM 7/7/7-21

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharms	ORTHO-NOVUM 7/7/7-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018985-001	Apr 4, 1984	➤ Sign Up	➤ Sign Up
Janssen Pharms	ORTHO-NOVUM 7/7/7-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018985-001	Apr 4, 1984	➤ Sign Up	➤ Sign Up
Janssen Pharms	ORTHO-NOVUM 7/7/7-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018985-001	Apr 4, 1984	➤ Sign Up	➤ Sign Up
Janssen Pharms	ORTHO-NOVUM 7/7/7-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018985-001	Apr 4, 1984	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

or, see our see our flat-rate plans

Summary for ORTHO-NOVUM 7/7/7-21

Synonyms for ORTHO-NOVUM 7/7/7-21

For more information try a trial or see the plans and pricing